Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

CARMA Therapeutics
3401 Grays Ferry Ave.
Philadelphia, PA 19146
https://carmatherapeutics.com/

CARMA Therapeutics is being built upon innovative technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out from the laboratory of Saar Gill, MD, PhD, assistant professor of Hematology Oncology in the Perelman School of Medicine at the University of Pennsylvania. 'We hypothesized early on that focusing on different effector cells, other than T cells, might be more effective in trying to tackle solid tumors, which has been a challenge for T cell therapies. The innate biology drove us to try macrophages,' says Dr. Gill, co-founder of CARMA Therapeutics, who conducts bench and clinical research on chimeric antigen receptor (CAR) T cells, and now on CAR macrophages.

Key Contact
Name
Bruce A. Peacock
Title
Executive Chairman
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
06/12/17 undisclosed First Round AbbVie Biotech Ventures
Grazia Equity
HealthCap
IP Group
undisclosed